Position in ALKS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,112,818
+$391,439 QoQ
Shares Held
21,237
+4.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#205
of 421 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026EVOLVE PRIVATE WEALTH, LLC holds $14,662,232 across 14 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
12,735 | $6,900,205 | |
| 2 | ALKS |
Alkermes plc.
This page
|
21,237 | $1,112,818 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
24,865 | $900,113 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
5,036 | $848,767 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
186,864 | $786,697 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
28,789 | $708,497 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
17,010 | $697,920 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
70,740 | $592,801 |
All Filings in ALKS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,112,818 | 21,237 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $721,379 | 20,401 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $552,577 | 19,749 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||